temozolomide has been researched along with Colitis in 3 studies
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prognosis for recurrent/progressive Ewing sarcoma (ES) remains poor." | 6.74 | Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. ( Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH, 2009) |
| " Following tumor resection, the patient underwent concomitant radiation and temozolomide therapy that was complicated by CMV colitis and abdominal abscesses." | 3.91 | Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report. ( Bloch, O; Grimm, SA; Horbinski, CM; Kumthekar, PU; Lamano, JB; Quaggin-Smith, JA; Tate, MC, 2019) |
| "The prognosis for recurrent/progressive Ewing sarcoma (ES) remains poor." | 2.74 | Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. ( Casey, DA; Chou, AJ; Merchant, MS; Merola, PR; Meyers, PA; Price, AP; Wexler, LH, 2009) |
| "We report myelitis with consequent paraplegia as a potential neurological immune-related side effect of ipilimumab." | 1.40 | Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma. ( Ahmad, MW; Alken, S; Colleran, GC; Fitzpatrick, D; Kavanagh, EC; Kelly, CM; Lyons, TG; Murray, B; O'Kane, GM, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lamano, JB | 1 |
| Quaggin-Smith, JA | 1 |
| Horbinski, CM | 1 |
| Tate, MC | 1 |
| Grimm, SA | 1 |
| Kumthekar, PU | 1 |
| Bloch, O | 1 |
| O'Kane, GM | 1 |
| Lyons, TG | 1 |
| Colleran, GC | 1 |
| Ahmad, MW | 1 |
| Alken, S | 1 |
| Kavanagh, EC | 1 |
| Fitzpatrick, D | 1 |
| Murray, B | 1 |
| Kelly, CM | 1 |
| Casey, DA | 1 |
| Wexler, LH | 1 |
| Merchant, MS | 1 |
| Chou, AJ | 1 |
| Merola, PR | 1 |
| Price, AP | 1 |
| Meyers, PA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Assessment of MGMT Promoter Methylation and Clinical Benefit From Temozolomide-based Therapy in Ewing Sarcoma Patients[NCT03542097] | 82 participants (Actual) | Observational | 2014-04-15 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for temozolomide and Colitis
| Article | Year |
|---|---|
Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Camptotheci | 2009 |
2 other studies available for temozolomide and Colitis
| Article | Year |
|---|---|
Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report.
Topics: Aged; Brain Neoplasms; Chemoradiotherapy; Colitis; Cytomegalovirus Infections; Female; Glioblastoma; | 2019 |
Late-onset paraplegia after complete response to two cycles of ipilimumab for metastatic melanoma.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Alkylating; Colitis; Dacarbazine; Fluorodeoxyglucose | 2014 |